Gapping down
In reaction to disappointing earnings/guidance:
- INFN -23.9%, PRMW -21.2%, MB -20.8%, ZG -19%, MED -15.8%, AXDX -15.6%, INGN -15.2%, CHUY -14.6%, FTR -14.6%, TRUE -14.2%, ICHR -12.7%, KORS -12.2%, DF -12.2%, CTSO -11.9%, COTY -10.9%, JAZZ -8.8%, HEAR -8.6%, MYGN -8.6%, CWH -8.3%, RRGB -7.7%, UCTT -7.6%, DLPH -7.6%, AKRX -7.2%, DXC -7.2%, MTCH -7.1%, DAR -6.8%, WEN -6.3%, VSLR -6.1%, SMG -5.5%, HCKT -4.3%, ENPH -3.9%, GDDY -3.4% (also approves repurchase of up to $500 mln of the company's Class A common stock), DISH -3.2%, PAAS -3.1%, SRLP -3%, STKL -2.9%, SUPN -2.8%, SCSC -2.7%, ACHN -2.7%, DPLO -2.4%, RESI -2.4%, IAG -2.2%, DXCM -2.2%, MODN -2.1%, ZAGG -2%, REGI -2%, CLNY -1.6%, AFMD -1.5%, GNL -1.4%, TWO -1.3%, KTOS -1.1%, BWXT -1.1%, MBI -1%, .
Other news:
- COMM -4.7% (CNBC reporting Arris [ARRS] is near a deal to be acquired by CommScope)
- IAC -2.1% (following MTCH results and ahead of its own earnings release tomorrow after the close)
- ENDP -1% (announces 'positive' results from Phase 3 RELEASE studies of collagenase clostridium histolyticum in patients with cellulite)
- RDFN -1% (following Z / ZG results; reports earnings Nov 8)
Analyst comments:
- MODN -2.1% (downgraded to Hold at Needham)
![]()